Your browser doesn't support javascript.
loading
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Rebbeck, Timothy R; Mitra, Nandita; Wan, Fei; Sinilnikova, Olga M; Healey, Sue; McGuffog, Lesley; Mazoyer, Sylvie; Chenevix-Trench, Georgia; Easton, Douglas F; Antoniou, Antonis C; Nathanson, Katherine L; Laitman, Yael; Kushnir, Anya; Paluch-Shimon, Shani; Berger, Raanan; Zidan, Jamal; Friedman, Eitan; Ehrencrona, Hans; Stenmark-Askmalm, Marie; Einbeigi, Zakaria; Loman, Niklas; Harbst, Katja; Rantala, Johanna; Melin, Beatrice; Huo, Dezheng; Olopade, Olufunmilayo I; Seldon, Joyce; Ganz, Patricia A; Nussbaum, Robert L; Chan, Salina B; Odunsi, Kunle; Gayther, Simon A; Domchek, Susan M; Arun, Banu K; Lu, Karen H; Mitchell, Gillian; Karlan, Beth Y; Walsh, Christine; Lester, Jenny; Godwin, Andrew K; Pathak, Harsh; Ross, Eric; Daly, Mary B; Whittemore, Alice S; John, Esther M; Miron, Alexander; Terry, Mary Beth; Chung, Wendy K; Goldgar, David E; Buys, Saundra S.
Affiliation
  • Rebbeck TR; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia2Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
  • Mitra N; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
  • Wan F; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
  • Sinilnikova OM; Centre de Recherche en Cancérologie de Lyon, UMR Inserm, Centre Léon Bérard, Lyon, France.
  • Healey S; Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia.
  • McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Mazoyer S; Centre de Recherche en Cancérologie de Lyon, UMR Inserm, Centre Léon Bérard, Lyon, France.
  • Chenevix-Trench G; Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia.
  • Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Nathanson KL; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia6Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
  • Laitman Y; Sheba Medical Center, Tel Aviv, Israel.
  • Kushnir A; Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel Hashomer, Israel.
  • Paluch-Shimon S; Sheba Medical Center, Tel Aviv, Israel.
  • Berger R; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Zidan J; Oncology Institute, Rivkah Ziv Medical Center Zefat, Israel.
  • Friedman E; Sheba Medical Center, Tel Aviv, Israel.
  • Ehrencrona H; Department of Oncology, Lund University, Lund, Sweden12Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Stenmark-Askmalm M; Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Einbeigi Z; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Loman N; Department of Oncology, Lund University, Lund, Sweden.
  • Harbst K; Department of Oncology, Lund University, Lund, Sweden.
  • Rantala J; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
  • Melin B; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Huo D; Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois.
  • Olopade OI; Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois.
  • Seldon J; UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Ganz PA; UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Nussbaum RL; Department of Medicine and Genetics, University of California, San Francisco.
  • Chan SB; Cancer Risk Program, Helen Diller Family Cancer Center, University of California, San Francisco.
  • Odunsi K; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
  • Gayther SA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
  • Domchek SM; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia6Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
  • Arun BK; University of Texas MD Anderson Cancer Center, Houston.
  • Lu KH; University of Texas MD Anderson Cancer Center, Houston.
  • Mitchell G; Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia 25Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
  • Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City.
  • Pathak H; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City.
  • Ross E; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Daly MB; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California.
  • Whittemore AS; Cancer Risk Program, Helen Diller Family Cancer Center, University of California, San Francisco.
  • John EM; Department of Epidemiology, Cancer Prevention Institute of California, Fremont.
  • Miron A; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Terry MB; Department of Epidemiology, Columbia University, New York, New York.
  • Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, New York.
  • Goldgar DE; Department of Dermatology, University of Utah School of Medicine, Salt Lake City.
  • Buys SS; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City.
JAMA ; 313(13): 1347-61, 2015 Apr 07.
Article de En | MEDLINE | ID: mdl-25849179
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Tumeurs du sein / Gène BRCA1 / Prédisposition génétique à une maladie / Gène BRCA2 / Mutation Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Middle aged Langue: En Journal: JAMA Année: 2015 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Tumeurs du sein / Gène BRCA1 / Prédisposition génétique à une maladie / Gène BRCA2 / Mutation Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Middle aged Langue: En Journal: JAMA Année: 2015 Type de document: Article Pays de publication: États-Unis d'Amérique